Neurotrope Provides Business Update and Reports Second Quarter 2018 Financial Results

Neurotrope, Inc. (NASDAQ: NTRP) today provided a business update outlining recent clinical development progress and other noteworthy events that occurred subsequent to the end of the quarter and unaudited financial results for the quarter ended June 30, 2018.

Intuitive Venture PartnersAugust 13, 2018neurotrope, 2018

Entera Bio Ltd. Announces Appointment of Mr. Gerald Lieberman as Chairman of the Board of Directors

Entera Bio Ltd. (NASDAQ: ENTX and ENTXW), announced today the appointment of Mr. Gerald Lieberman as the chairman of the board of directors, effective as of August 6, 2018.

READ MORE

Intuitive Venture PartnersAugust 9, 2018entera bio, 2018

Solbright and M2M Spectrum Networks Merge to Create Iota Communications, Inc.

Solbright Group, Inc. (OTC: SBRT) and M2M Spectrum Networks, LLC today announce the signing of a merger agreement creating the first publicly-traded, pure-play, fully-featured IoT network operating company in the U.S., Iota Communications, Inc. (“Iota”).

Intuitive Venture PartnersJuly 31, 2018iota communications, 2018

Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes

Innovate Biopharmaceuticals Inc. (NASDAQ: INNT) announced today that it has been added as a member of the broad-market Russell 3000®, 2000® and Microcap® Indexes as part of the 2018 Russell indexes reconstitution.

Intuitive Venture PartnersJune 25, 2018innovate biopharmaceuticals, 2018

Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D.

Innovate Biopharmaceuticals, Inc. (“Innovate”) (NASDAQ: INNT) today announced the appointment of Saira Ramasastry, to its Board of Directors (Board).

Intuitive Venture PartnersJune 13, 2018innovate biopharmaceuticals, 2018

Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on June 5, 2018

Innovate Biopharmaceuticals, Inc. (“Innovate”) (NASDAQ: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory disease, intends to present on larazotide for celiac disease at BIO 2018 in Boston on Tuesday, June 5th.

Intuitive Venture PartnersMay 22, 2018innovate biopharmaceuticals, 2018

Neurotrope, In Consultation With Leading Neuroscientists, Completes the Study Design for its Confirmatory Phase 2 Trial in Advanced Alzheimer’s Patients

Neurotrope, Inc. (NASDAQ: NTRP) announces completion of the study design for its confirmatory Phase 2 clinical trial in moderate to severe Alzheimer’s disease.

Intuitive Venture PartnersMay 7, 2018neurotrope, 2018

CALIENT Edge|640™ Optical Circuit Switch Offers Industry’s Highest Density Fiber Optic Cross Connect

CALIENT Technologies, Inc., the global leader for optical switching technology, today announced the Edge|640™, a new Optical Circuit Switch (OCS) with 640 fiber-optic cross connections – up to twice the capacity of the company’s market leading S320 OCS.

Intuitive Venture PartnersMarch 15, 2018calient technologies, 2018